Literature DB >> 24191501

[Effectiveness of multiplex ligation dependent probe amplification (MLPA) in prenatal diagnosis of common aneuploidies].

Anna Jóźwiak1, Julia Bijok, Diana Massalska, Barbara Pawłowska, Alicja Ilnicka, Joanna Bogdanowicz, Katarzyna Masternak-Wasiuk, Grzegorz Jakiel, Tomasz Roszkowski.   

Abstract

OBJECTIVES: To assess the effectiveness of the MLPA method (multiplex ligation dependent probe amplification) in prenatal diagnosis of common aneuploidies and compare its concordance with traditional karyotyping.
MATERIAL AND METHODS: From October 2008 until July 2012 we performed 195 MLPA (MRC-Holland) tests with the P095 probe mix on DNA extracted from chorionic villi or amniotic fluid from pregnant women with elevated risk for abnormal fetal karyotype and 5 tests on miscarriage DNA samples. Cell culture and traditional karyotyping were performed in parallel.
RESULTS: Traditional karyotyping was successfully performed in 192 cases (98.5%; 192/195). In 52 cases the fetal karyotype was abnormal (26.8%). The most common findings included aneuploidies of the following chromosomes: 13, 18, 21, X, Y (86.5%, 45/52). There were 179 conclusive and 1 inconclusive MLPA result (92.3%; 180/195). The absolute specificity and sensitivity of the MLPA test were 100%. In 9 cases traditional karyotyping revealed aberrations impossible to detect with the MLPA P095 kit. The MLPA reaction was successfully performed on all miscarriage DNA samples.
CONCLUSIONS: MLPA is an effective method for detecting common aneuploidies. Its effectiveness for miscarriage DNA samples remains to be elucidated in further studies.

Entities:  

Mesh:

Year:  2013        PMID: 24191501     DOI: 10.17772/gp/1624

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  1 in total

1.  In-house genetic counseling increases the detection of abnormal karyotypes-a 26-year experience in prenatal diagnosis in a single tertiary referral hospital in Poland.

Authors:  Julia Bijok; Anna Kucińska-Chahwan; Diana Massalska; Alicja Ilnicka; Grzegorz Panek; Tomasz Roszkowski
Journal:  J Assist Reprod Genet       Date:  2020-05-19       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.